0ZUQuZQ7oqY https://histock.tw/talk/live.aspx?name=gtalk&id=1280 20240612 何毅里長伯

台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效

健亞

(4130)
可現股當沖
  • 股價
    24.30
  • 漲跌
    ▼0.25
  • 漲幅
    -1.02%
  • 成交量
    157
  • 產業
    上櫃 生技醫療類股
  • 150人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
健亞 (4130)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/17     後一日»

券商獲利排行 - 2024/04/17

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  0.34%1.51.20.3-991824.324.224.324.3
  1.13%1.11.1004424.424.224.524.3
  0.44%0.90.40.4-44824.424.324.424.3
  0.20%0.700.71515024.324.3024.3
  0.24%0.70.60-741124.324.224.324.3
  0.41%0.600.666024.224.2024.3
  1.03%0.50.5002224.424.324.524.3
  0.41%0.500.555024.224.2024.3
  0.41%0.500.555024.224.2024.3
  0.34%0.500.566024.224.2024.3
  0.21%0.500.51010024.324.3024.3
  1.01%0.50.5002224.424.324.524.3
  0.82%0.400.4-20224.5024.524.3
  0.41%0.400.444024.224.2024.3
  1.23%0.30.3001124.424.224.524.3
  0.41%0.300.323124.224.224.224.3
  0.09%0.300.31214224.324.324.324.3
  0.21%0.20.20-21324.324.224.324.3
  0.62%0.100.111024.224.2024.3
  0.62%0.100.111024.224.2024.3
  0.10%0.100.166024.324.3024.3
  0.41%0.100.111024.224.2024.3
  0.41%0.100.111024.224.2024.3
  0.41%0.100.111024.224.2024.3
  0.41%0.100.111024.224.2024.3
  0.41%0.100.111024.224.2024.3
  0.21%0.100.122024.324.3024.3
  0.41%0.100.111024.224.2024.3
  0.04%0.100.11010024.324.3024.3
  0.10%00012124.324.324.324.3
  0.21%00011024.324.3024.3
  0.21%00011024.324.3024.3
  0.21%00011024.324.3024.3
  0.21%00011024.324.3024.3
  0.07%00011024.324.324.424.3
  0.00%000-60624.3024.324.3
  0.00%000-60624.3024.324.3
  0.00%000-50524.3024.324.3
  0.00%000-30324.3024.324.3
  0.00%000-10124.3024.324.3
  0.00%000-10124.3024.324.3
  0.00%000-10124.3024.324.3
  0.00%000-10124.3024.324.3
  0.00%000-10124.3024.324.3
  0.00%000-10124.3024.324.3
   00000024.424.4024.3
   00000024.4024.424.3
   00000024.324.424.224.3
   00000024.2024.224.3
   00000024.5024.524.3

券商虧損排行 - 2024/04/17

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.19%-5.8-5.800202024.424.524.224.3
  -0.41%-20-2-1902024.224.324.224.3
  -0.34%-1.60-1.6-2002024.2024.224.3
  -0.62%-0.90-0.9-60624.2024.224.3
  -0.21%-0.50-0.5-1001024.3024.324.3
  -0.15%-0.30-0.388024.324.3024.3
  -0.34%-0.20-0.2-30324.2024.224.3
  -0.41%-0.10-0.1-10124.2024.224.3
  -0.21%-0.10-0.1-20224.3024.324.3
  -0.22%-0.10-0.1-10124.2024.224.3
  -0.21%000-10124.3024.324.3
  -0.21%000-10124.3024.324.3
  -0.21%000-10124.3024.324.3
  0.00%00023024.324.324.524.3
  0.00%00033024.324.3024.3
  0.00%00011024.324.3024.3
  0.00%00011024.324.3024.3
  0.00%00011024.324.3024.3
  0.00%00011024.324.3024.3
  0.00%00011024.324.3024.3
   00000024.324.424.224.3
   00000024.2024.224.3
   00000024.5024.524.3
   00000024.3024.324.3
   00000024.224.2024.3
   00000024.3024.324.3
   00000024.5024.524.3
   00000024.4024.424.3
   00000024.3024.324.3
   00000024.224.2024.3
   00000024.3024.324.3
   00000024.224.2024.3
   00000024.2024.224.3
   00000024.424.4024.3
   00000024.2024.224.3
   00000024.2024.224.3
   00000024.2024.224.3
   00000024.3024.324.3
   00000024.4024.424.3
   00000024.224.2024.3
   00000024.2024.224.3
  0.00%000-10124.3024.324.3
  0.00%000-10124.3024.324.3
  0.00%000-10124.3024.324.3
  0.00%000-10124.3024.324.3
  0.00%000-10124.3024.324.3
  0.00%000-10124.3024.324.3
  0.00%000-30324.3024.324.3
  0.00%000-50524.3024.324.3
  0.00%000-60624.3024.324.3
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章